OpenServicesEuropeanOpen

Preclinical toxicity study radioactive tracer

Stichting Amsterdam UMC · Open · 1 lots · 427460
Type
Services
73100000 · Research and experimen
Estimated value
Not published
To deadline
48d
Aug 3, 2026 · 07:00
Knock-outs
0
exclusion grounds
Award basis
Best price-quality ratio
1 criteria
Assess manuallyconfidence high

This tender concerns the execution of a standardized preclinical toxicity study for a new radiopharmaceutical by a certified laboratory. The award takes place on the basis of the lowest price.

Services · Open · European procedure

EuropeanComplete timeline
Contracting authority
Stichting Amsterdam UMC
Noord-Holland
Contract type
Services
Open
Estimated value
Estimate not published
Submission deadline
August 3, 2026
07:00
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Research and experimental development
Location
Amsterdam, Noord-Holland
CharacteristicsCPV 73ServicesEU tenderPreclinical toxicity studyRadioactive tracerEMA guidelines

01What is being requested

Execution of a preclinical toxicity study in accordance with EMA guidelines for a new radiopharmaceutical. The assignment includes an extended single dose toxicity study, an MTD study with 3 doses, a cytokine release study and an antibody cross reactivity study, with reporting no later than 31 October 2026.

The purpose of this Tender is to contract 1 Entrepreneur for the execution of a toxicity study in accordance with EMA guidelines (ICH-M3(R2)).

73100000Services
1Preclinical toxicity study radioactive tracer

02Strategic insight

Strategic insight · AI analysis
Ensure that the laboratory complies with strict GLP and AAALAC certifications. Because the award is based solely on the lowest price, a sharp price quotation is essential. Check whether all mandatory attachments are submitted exactly according to the requested filename.
Read automatically from the tender documents using AI. Always verify against the original documents.

03Points of attention

Important · 6
The laboratory must be GLP and AAALAC certified.Important
Offering variants is not permitted.Important
All prices must be all-in and excluding VAT.Important
The bid must be submitted in the Dutch language.Important
A Chamber of Commerce extract must not be older than 6 months.Important
Bidders must accept a validity period of 180 days.Important

04Can I take part?

Technical — Execution of the study by a GLP (Good Laboratory Practice) and an AAALAC (American Association for Accreditation of Laboratory Animal Care) certified laboratory.
Financial — Compliance with the financial and economic capacity as stated in the suitability requirements.

05Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

06Award criteria

lowest priceweight n/a

The award will be made to the most economically advantageous tender on the basis of the lowest price, as the assignment consists of standardized studies with fully determined content and methodology.

07Process & timeline

Publication of the Tender
2 juni 2026
Deadline for questions and comments
30 juni 2026 12:00 uur
Deadline for publication of the Note of Clarification
7 juli 2026
Deadline for receipt of Tenders
3 augustus 2026 9:00 uur
Assessment of Award Criteria and Suitability Requirements
3 augustus 2026 9:15 uur
Communication of Award Decision
11 augustus 2026
Conclusion of the agreement
1 september 2026
Commencement of the Assignment
1 september 2026
Final reporting toxicity study
31 oktober 2026

08Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for diensten is € 221.000, for reference.

09Likely competitors

#Likely bidderFitWins
1Witteveen+Bos Raadgevende ingenieurs B.V.SME8011×
2Haskoning Nederland B.V.SME77
3Sweco Nederland B.V. SME76
4I&O Research B.V.SME7410×
5Arcadis Nederland B.V.SME73
6Antea Nederland BVSME71

10Tender documents

Bijlage 8 Dienstenovereenkomst Preklinische toxiciteitsstudie radioactieve tracerpdfJun 3, 2026 · 210 KB
Bijlage 7 Format vragen Nota van Inlichtingen Preklinische toxiciteitsstudie radioactieve tracerxlsxJun 3, 2026 · 14 KB
Bijlage 5.0 Eisen Preklinische toxiciteitsstudie radioactieve tracer [naam Ondernemer]docxJun 3, 2026 · 50 KB
Bijlage 5.1 Programma van Eisen Preklinische toxiciteitsstudie radioactieve tracer [naam Ondernemer]xlsxJun 3, 2026 · 29 KB
Amsterdam UMC Inschrijvingsleidraad EA Preklinische toxiciteitsstudie radioactieve tracer TN 578260pdfJun 3, 2026 · 394 KB
Bijlage 2 (UEA) Preklinische toxiciteitsstudie radioactieve tracer [naam Ondernemer]pdfJun 3, 2026 · 490 KB
Bijlage 6 Prijsopgaveformulier Preklinische toxiciteitsstudie radioactieve tracerxlsxJun 3, 2026 · 14 KB
Bijlage 4 Geschiktheidseisen Preklinische toxiciteitsstudie radioactieve tracer [naam Ondernemer]docxJun 3, 2026 · 45 KB
Bijlage 1 Documentoverzicht Preklinische toxiciteitsstudie radioactieve tracerxlsxJun 3, 2026 · 20 KB
Bijlage 3 Format Anti-collusieverklaring Preklinische toxiciteitsstudie radioactieve tracer [naam Ondernemer]docxJun 3, 2026 · 55 KB
Bijlage 8.1 AIV Aanvullingen versie januari 2024pdfJun 3, 2026 · 198 KB
Bijlage 8.1 Algemene Inkoopvoorwaarden Amsterdam UMC versie januari 2024pdfJun 3, 2026 · 1184 KB

11Legal themes that may be relevant here

12Frequently asked questions

What is the purpose of the assignment?
The purpose is to contract 1 entrepreneur for the execution of a <strong/em>toxicity study in accordance with the EMA guidelines (ICH-M3(R2)).
Which specific guidelines must the research comply with?
The execution of the research must take place in accordance with the <strong/em>EMA guidelines (ICH-M3(R2)).

Automatically compiled from the official tender data and documents.

13Estimated value versus the market

p25
€ 165K
median
€ 413K
p75
€ 1,0 mln
deze opdracht

Gegunde waarden in CPV 73 · diensten n=468